Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2008 | 2 |
2009 | 2 |
2010 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
J Pharmacol Exp Ther. 2010 Dec;335(3):589-99. doi: 10.1124/jpet.110.170977. Epub 2010 Sep 8.
J Pharmacol Exp Ther. 2010.
PMID: 20826567
Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor.
Shemesh R, Hermesh C, Toporik A, Levine Z, Novik A, Wool A, Kliger Y, Rosenberg A, Bathgate RA, Cohen Y.
Shemesh R, et al. Among authors: hermesh c.
Ann N Y Acad Sci. 2009 Apr;1160:78-86. doi: 10.1111/j.1749-6632.2009.03827.x.
Ann N Y Acad Sci. 2009.
PMID: 19416163
Item in Clipboard
A novel peptide agonist of formyl-peptide receptor-like 1 (ALX) displays anti-inflammatory and cardioprotective effects.
Hecht I, Rong J, Sampaio AL, Hermesh C, Rutledge C, Shemesh R, Toporik A, Beiman M, Dassa L, Niv H, Cojocaru G, Zauberman A, Rotman G, Perretti M, Vinten-Johansen J, Cohen Y.
Hecht I, et al. Among authors: hermesh c.
J Pharmacol Exp Ther. 2009 Feb;328(2):426-34. doi: 10.1124/jpet.108.145821. Epub 2008 Nov 20.
J Pharmacol Exp Ther. 2009.
PMID: 19023040
Item in Clipboard
Membrane-induced step in the activation of Sendai virus fusion protein.
Ben-Efraim I, Kliger Y, Hermesh C, Shai Y.
Ben-Efraim I, et al. Among authors: hermesh c.
J Mol Biol. 1999 Jan 15;285(2):609-25. doi: 10.1006/jmbi.1998.2370.
J Mol Biol. 1999.
PMID: 9878433
Item in Clipboard
A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
Tiran Z, et al. Among authors: hermesh c.
Clin Cancer Res. 2008 Jul 15;14(14):4612-21. doi: 10.1158/1078-0432.CCR-08-0108.
Clin Cancer Res. 2008.
PMID: 18628476
Item in Clipboard
Cite
Cite